Abstract
Background Telemedicine, which involves utilising technologies for remote health care delivery, proved useful to continue offering certain health services during the coronavirus disease 2019 (COVID-19) lockdown. However, the extent of its effectiveness in delivering pre-exposure prophylaxis services for HIV prevention remains underexplored from the viewpoint of health care providers. Therefore, this study aimed to assess the experiences of health care professionals in Mexico who utilised telemedicine for delivering pre-exposure prophylaxis services during the COVID-19 contingency. Methods A qualitative study was performed: 15 virtual interviews with health care professionals were conducted, transcribed and coded in ATLAS.ti. Results The results indicate that telemedicine effectively mitigated COVID-19 exposure, facilitated users’ access to pre-exposure prophylaxis counselling, minimised waiting times and enhanced health care professionals’ perceived control during sessions. While implementing remote services, certain organisational challenges, which were somewhat latent before the pandemic, became more apparent: colleagues recognised the necessity for more formal communication channels to disseminate information effectively. Additionally, there was a recognised need for electronic patient files to streamline data-sharing processes. An optimal approach would involve a blend of face-to-face and virtual services, contingent upon the availability of essential infrastructure, well-defined implementation protocols and comprehensive training programs. Conclusions Telemedicine streamlined certain processes, garnered positive acceptance from healthcare professionals and holds promise as a valuable post-pandemic tool for improving retention among pre-exposure prophylaxis users.
Funder
United Nations Population Fund
Reference31 articles.
1. UNAIDS. UNAIDS global AIDS update 2022. pp. 1–376. 2022. Available at [cited 22 January 2023]
2. UNAIDS. Prevailing against pandemics by putting people at the centre. pp. 1–92. 2020. Available at [cited 16 February 2023]
3. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd edn. World Health Organization; 2016. Available at
4. CENSIDA. 3er trimestre de 2022. Boletín de atención integral de personas con VIH. pp. 1–41. 2022. Available at [cited 24 January 2023]
5. Secretaría de Salud. Sistema de vigilancia epidemiológica de VIH. Informe histórico de VIH 4to trimestre. 2023. Available at [cited 20 September 2023]